Le mode conseil est activé Arrêter
Pour la navigation rapide entre les blocs

Organisation: Sanofi
LEI 549300E9PC51EN656011, SWIFT SAAVFRPPXXX

Nom de l'organisation
Sanofi SA
Nom du pays
France
Pays d'enregistrement
France
Secteur économique
Production de médicaments et biotechnologies
Dette obligataire
15.403 millions USD

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Dernières données pour

Cotations

Requête envoyé
Accès refusé
Envoyer la requête
Les cotations fournis par les fournisseurs d’information sont de nature indicative

Profile

Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. Sanofi has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products. In December 2011, Sanofi announced that it completed the divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International, Inc. The Company is active domestically and abroad, including other European countries, North and Latin Americas, Asia, Africa and Middle East. As of January 31, 2012, the Companys major shareholder was Loreal with a stake of 8.82%.

Récompenses

Actualités

28/03/2024 Moody's Investors Service revised outlook on Sanofi to positive and affirmed at "A1" (LT- local currency) credit rating
28/03/2024 Moody's Investors Service revised outlook on Sanofi to positive and affirmed at "A1" (LT- foreign currency) credit rating
15/12/2023 Fitch Ratings withdrew LT Int. Scale (foreign curr.) credit rating for Sanofi
14/12/2023 Fitch Affirms Sanofi at 'AA-'/ Stable; Withdraws All Ratings (Rating action commentary)
22/05/2023 Fitch Ratings upgrades LT Int. Scale (foreign curr.) credit rating of Sanofi to "AA-" from "A+"; outlook stable
Toutes les actualités de l'organisation

Documents

Etats financiers IFRS / US GAAP

2023
II q ang
IV q ang
2022
II q ang
IV q ang
2021
II q ang
IV q ang
2020
II q ang
IV q ang
2019
II q ang
IV q ang
2018
II q ang
IV q ang
2017
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Actions

Dernières émissions

Montrer tout

Dette obligataire par devise

Montrer tout Cacher

Codes

  • LEI
    549300E9PC51EN656011
  • SWIFT
    SAAVFRPPXXX
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • ICB
    4.500 Health Care
  • CIK
    0001121404
  • EIN
    13-3529324

Notations de crédit et notations d’ESG

Macroéconomie

Vous devez vous inscrire pour y accéder.